AcelRx Pharmaceuticals Inc. (ACRX)

1.72
0.03 1.40
NASDAQ : Health Technology
Prev Close 1.74
Open 1.75
Day Low/High 1.71 / 1.75
52 Wk Low/High 1.70 / 4.09
Volume 305.54K
Avg Volume 818.50K
Exchange NASDAQ
Shares Outstanding 79.57M
Market Cap 141.64M
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

AcelRx Pharmaceuticals Reports Third Quarter 2019 Financial Results

AcelRx Pharmaceuticals Reports Third Quarter 2019 Financial Results

Exceeded 125 REMS-certified facilities two months ahead of year-end goal

Stocks Under $10 Weekly Summary

We did some buying last week, adding to four positions as the broader market marched higher.

Stocks Under $10 Weekly Summary

We exited one position during a mixed week for the portfolio.

Stocks Under $10 Weekly Summary

We re-initiated a position in USA Technologies last week.

Stocks Under $10 Weekly Summary

It took late-week rallies to trim losses in a handful of portfolio names, though a few had solid weeks.

Stocks Under $10 Weekly Summary

We shed our remaining shares of Sutter Rock Capital last week as the Russell 2000 declined.

Stocks Under $10 Weekly Summary

It was a challenging week for the portfolio, as it was for the markets in general, as only of our active positions finished the week higher.

Stocks Under $10 Weekly Summary

Last week we started a small position in Digital Turbine and added to two other holdings.

Stocks Under $10 Weekly Summary

We exited one position and initiated a new one as eight of our holdings outpaced the Russell 2000's 5% increase last week.

Stocks Under $10 Weekly Summary

We made several trades last week, as all the major stock market indices posted gains.

Stocks Under $10 Weekly Summary

We saw some meaningful swings, both positive and negative, in several portfolio positions last week.

Stocks Under $10 Weekly Summary

We trimmed our holdings in 2 positions and added to another last week as the Russell 2000 took a hit.

Stocks Under $10 Weekly Summary

We made several trades last week as all the major domestic stock market indices moved lower for the five days.

Stocks Under $10 Weekly Summary

Our portfolio fell along with the broader market (especially small-caps), but there were some bright spots as well.

Earnings Buffet: Updates on 4 Portfolio Names

Here's our current thinking on AcelRx Pharmaceuticals, Antares Pharma, CPI Aerostructures and Pareteum.

Stocks Under $10 Weekly Summary

While the portfolio experienced some pain last week along with the broader market, 12 of our holdings beat the Russell 2000 either on an absolute or relative basis.

AcelRx Pharmaceuticals Reports Second Quarter 2019 Financial Results

AcelRx Pharmaceuticals Reports Second Quarter 2019 Financial Results

51 REMS-certified facilities and 43 formulary approvals since launch

Stocks Under $10 Weekly Summary

We exited a position last week for a nice gain as the market continued to rise.

Interesting ACRX Put And Call Options For March 2020

Interesting ACRX Put And Call Options For March 2020

Investors in AcelRx Pharmaceuticals Inc saw new options begin trading this week, for the March 2020 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Stocks Under $10 Weekly Summary

As the momentum of earnings season rose last week, we made several trades including initiating a new position in Innovative Solutions and Support.

Stocks Under $10 Weekly Summary

We added to one position last week as as the small-cap heavy Russell 2000 dipped.

Stocks Under $10 Weekly Summary

We added to one position and initiated another during a shortened holiday week.

Stocks Under $10 Weekly Summary

We initiated a new position and added to a couple of others as we closed the books on the second quarter.

TheStreet Quant Rating: D- (Sell)